Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6251
VanEck Green Bond ETF
GRNB
$192M
| $1K | ﹤0.01% |
50
+40
| +400% | +$1.07K |
2017 Q1
2 quarters
|
|
6252
Gyre Therapeutics
GYRE
$746M
| $1K | ﹤0.01% |
+33
| New | +$989 |
2017 Q3
0 quarters
|
|
6253
Imunon
IMNN
$6.06M
| $1K | ﹤0.01% |
2
-3
| -60% | -$924 |
2016 Q4
3 quarters
|
|
6254
Renaissance IPO ETF
IPO
$149M
| $1K | ﹤0.01% |
+45
| New | +$1.16K |
2017 Q3
0 quarters
|
|
6255
Kiora Pharmaceuticals
KPRX
$11.2M
| – | – |
0
| – | – |
2016 Q3
4 quarters
|
|
6256
LGL Group
LGL
$86.1M
| $1K | ﹤0.01% |
530
| – | – |
2013 Q4
15 quarters
|
|
6257
Comstock
LODE
$168M
| $1K | ﹤0.01% |
16
| – | – |
2013 Q4
15 quarters
|
|
6258
Lightpath Technologies
LPTH
$681M
| $1K | ﹤0.01% |
513
-4,837
| -90% | -$12.5K |
2017 Q1
2 quarters
|
|
6259
Marathon Digital Holdings
MARA
$3.73B
| $1K | ﹤0.01% |
150
-15,793
| -99% | -$84.5K |
2016 Q3
4 quarters
|
|
6260
Microbot Medical
MBOT
$71.9M
| $1K | ﹤0.01% |
63
-430
| -87% | -$7.58K |
2016 Q4
3 quarters
|
|
6261
Mannatech
MTEX
$15.2M
| $1K | ﹤0.01% |
61
| – | – |
2013 Q3
16 quarters
|
|
6262
Natural Alternatives International
NAII
$7.14M
| $1K | ﹤0.01% |
61
-313
| -84% | -$3.24K |
2015 Q4
7 quarters
|
|
6263
Global X US Infrastructure Development ETF
PAVE
$13.6B
| $1K | ﹤0.01% |
+35
| New | +$510 |
2017 Q3
0 quarters
|
|
6264
Phunware
PHUN
$43.2M
| $1K | ﹤0.01% |
+2
| New | +$1.01K |
2017 Q3
0 quarters
|
|
6265
Patriot National Bancorp
PNBK
$111M
| $1K | ﹤0.01% |
50
| – | – |
2013 Q4
15 quarters
|
|
6266
Axe Compute Inc
AGPU
$135M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
6267
Pioneer Power Solutions
PPSI
$34.2M
| $1K | ﹤0.01% |
110
-3,599
| -97% | -$23.1K |
2017 Q1
2 quarters
|
|
6268
Cerenome
CNSY
$14.6M
| – | – |
0
| – | – |
2013 Q2
17 quarters
|
|
6269
Pulmatrix
PULM
$5.33M
| $1K | ﹤0.01% |
2
| – | – |
2017 Q1
2 quarters
|
|
6270
RENN Fund
RCG
$19.9M
| $1K | ﹤0.01% |
+602
| New | +$809 |
2017 Q3
0 quarters
|
|
6271
Filana Therapeutics
FLNA
$39.5M
| $1K | ﹤0.01% |
376
-304
| -45% | -$1.09K |
2013 Q2
17 quarters
|
|
6272
DELISTED
Soleno Therapeutics
SLNO
| $1K | ﹤0.01% |
14
-5
| -26% | -$197 |
2017 Q1
2 quarters
|
|
6273
SenesTech
SNES
$3.63M
| – | – |
0
| – | – |
2017 Q2
1 quarter
|
|
6274
Travelzoo
TZOO
$53.3M
| $1K | ﹤0.01% |
166
-14,714
| -99% | -$137K |
2013 Q2
17 quarters
|
|
6275
UTStarcom
UTSI
$21.5M
| $1K | ﹤0.01% |
100
-19,093
| -99% | -$167K |
2017 Q1
2 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.